Bone marrow transplant consent: insight into patient motivations
Common side-effects of BTK inhibitors (ibrutinib and acalabrutinib) in the treatment of CLL
Is effective management of CLL as a chronic disease as good as a '"cure"?
Are complex karyotypes reliable prognostic markers for CLL?
Potential concerns with ventoclax and Richter's transformation